Modulation of 5‐HT release in the guinea‐pig brain following long‐term administration of antidepressant drugs
Authors:
Open Access
- 1 October 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 113 (2) , 485-495
Abstract
1 The aims of the present study were to determine whether long-term 5-hydroxytryptamine (5-HT) reuptake blockade and inhibition of type-A monoamine oxidase (MAO-A) lead to an enhancement of the electrically evoked release of tritium from guinea-pig brain slices preloaded with [3H]-5-HT, and to assess the sensitivity of the terminal 5-HT1D autoreceptor, the α2-adrenoceptor also located on 5-HT terminals, and the 5-HT3 receptor that modulates 5-HT release following these two types of antidepressant treatments. 2 The electrically evoked release of tritium was significantly enhanced following a 21-day treatment with the 5-HT reuptake blocker, paroxetine and the reversible MAO-A inhibitor, befloxatone, in preloaded slices of the hypothalamus, hippocampus and frontal cortex 48 h after removal of the osmotic minipumps used to deliver the drugs. 3 The inhibitory effect of the terminal 5-HT autoreceptor agonist, 5-methoxytryptamine, on the evoked release of tritium was attenuated in slices of the hypothalamus, hippocampus, but not frontal cortex, following the paroxetine treatment. In the befloxatone group, the effectiveness of 5-methoxytryptamine was unaltered in the same brain structures. 4 The sensitivity of the α2-adrenoceptor on 5-HT terminals, assessed using UK 14.304, was attenuated in hypothalamus, hippocampus, but not frontal cortex slices prepared from befloxatone-treated guinea-pigs and preloaded with [3H]-5-HT. The paroxetine treatment did not alter the sensitivity of this α2-adrenoceptor in the hypothalamus. 5 The sensitivity of the α2-adrenoceptor on noradrenaline terminals, also assessed using UK 14.304, was not altered in hippocampus and hypothalamus slices preloaded with [3H]-noradrenaline following the long-term befloxatone treatment. 6 In frontal cortex slices, [3H]-5-HT uptake was no longer significantly attenuated after a 21-day treatment with paroxetine, whereas it was still markedly inhibited in hypothalamus slices. The enhancing effect of paroxetine on the evoked release of [3H]-5-HT in the superfusion medium was no longer evident in frontal cortex slices of the paroxetine group. These data indicate that long-term 5-HT reuptake blockade desensitized the 5-HT transporter in the frontal cortex. 7 The capacity of the 5-HT3 receptor agonist, 2-methyl-5-HT, to enhance the electrically evoked release of tritium was not altered in hypothalamus, hippocampus, and frontal cortex slices prepared from befloxatone-treated guinea-pigs, but was significantly attenuated in the paroxetine group also treated for 21 days. Following a 2-day paroxetine treatment, the enhancing effect of 2-methyl-5-HT on tritium release was unaltered in frontal cortex slices.Keywords
This publication has 32 references indexed in Scilit:
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- 5-HT3 receptors which modulate [3H]5-HT release in the guinea pig hypothalamus are not autoreceptorsSynapse, 1993
- Chronic fluoxetine treatment upregulates 5‐HT uptake sites and 5‐HT2 receptors in rat brain: An autoradiographic studySynapse, 1993
- Endogenous Noradrenaline Activates α2‐Adrenoceptors on Serotonergic Nerve Endings in Human and Rat NeocortexJournal of Neurochemistry, 1993
- Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brainTrends in Pharmacological Sciences, 1989
- Single Unit Activity of Brain Monoamine‐Containing Neurons in Freely Moving AnimalsaAnnals of the New York Academy of Sciences, 1986
- Guinea Pig Striatum as a Model of Human Dopamine Deamination: The Role of Monoamine Oxidase Isozyme Ratio, Localization, and Affinity for Substrate in Synaptic Dopamine MetabolismJournal of Neurochemistry, 1985
- α1-adrenoceptor-mediated responses in the lateral geniculate nucleus are enhanced by chronic antidepressant treatmentEuropean Journal of Pharmacology, 1981
- Chronic antidepressant treatment enhances α-adrenergic and serotonergic responses in the facial nucleusLife Sciences, 1980
- Tricyclic Antidepressants: Long-Term Treatment Increases Responsivity of Rat Forebrain Neurons to SerotoninScience, 1978